Table 2. Characteristics of patients with visceral leishmaniasis, Germanya.
| No. | Exposure | Status | Sex | Age | Risk factor | Leishmania species | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 |
Italy |
Tourist |
M |
2 y |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 2 |
Italy |
Tourist |
F |
5 y |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 3 |
Italy |
Tourist |
M |
11 y |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 4 |
Spain |
Tourist |
F |
8 mo |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 5 |
Spain |
Tourist |
M |
9 mo |
Child |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 6 |
Iran |
Immigrant |
M |
7 y |
Child |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 7 |
Spain |
Tourist |
M |
43 y |
HIV |
L. donovani complex |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
No relapse for 6 months |
| 8 |
Spain (Ibiza) |
Tourist |
M |
48 y |
HIV |
L. donovani complex |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
No relapse for 8 months |
| 9 |
Portugal |
Visitor |
M |
29 y |
HIV |
n.d. |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
unknown |
| 10 |
France |
Tourist |
M |
31y |
HIV |
L. donovani complex |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
Relapse after 4 months; retreatment with Liposomal Amphotericin B; No relapse for 3 months |
| 11 |
Angola |
Immigrant |
M |
40 y |
HIV |
L. donovani complex |
Systemic pentavalent antimonials
Maintenance therapy:
HAART plus pentavalent antimonials once monthly |
unknown |
| 12 |
Togo |
Immigrant |
M |
37 y |
HIV |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 13 |
Italy (Sicily) |
Visitor |
M |
31 y |
Thymoma |
n.d. |
Liposomal amphotericin B |
Cured |
| 14 |
Italy (Ischia) |
Tourist |
M |
67 y |
Methotrexate/steroids |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 15 |
Italy (Sicily) |
Tourist |
M |
68 y |
Methotrexate |
n.d. |
Liposomal amphotericin B |
Cured |
| 16 |
Italy (Ischia) |
Tourist |
M |
70 y |
Splenectomy |
n.d. |
Liposomal amphotericin B |
Cured |
| 17 |
Spain |
Tourist |
M |
51 y |
Splenectomy |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 18 |
Greece (Korfu) |
Tourist |
M |
66 y |
Diabetes mellitus Hypertonus |
n.d. |
Liposomal amphotericin B |
Cured |
| 19 |
Spain |
Tourist |
M |
52 y |
Hypertonus
Hypercholesterolemia |
n.d. |
Liposomal amphotericin B |
Cured |
| 20 |
Greece (Korfu) |
Tourist |
M |
45 y |
Diabetes mellitus
Emphysema |
L. donovani complex |
Systemic pentavalent antimonoials |
Cured |
| 21 |
Tunisia |
Tourist |
M |
53 y |
Hypertonus |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 22 |
Malta |
Tourist |
F |
55 y |
- |
n.d. |
Liposomal amphotericin B |
Cured |
| 23 | China | Tourist | M | 67 y | - | n.d. | Liposomal amphotericin B | Cured |
an.d., not done; IFN, interferon.